Manyi Jing

1.1k total citations · 1 hit paper
43 papers, 768 citations indexed

About

Manyi Jing is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Manyi Jing has authored 43 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Pharmacology and 15 papers in Surgery. Recurrent topics in Manyi Jing's work include Helicobacter pylori-related gastroenterology studies (14 papers), Pharmacological Effects of Natural Compounds (12 papers) and Drug Transport and Resistance Mechanisms (6 papers). Manyi Jing is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (14 papers), Pharmacological Effects of Natural Compounds (12 papers) and Drug Transport and Resistance Mechanisms (6 papers). Manyi Jing collaborates with scholars based in China, Czechia and United States. Manyi Jing's co-authors include Shizhang Wei, Xiao Ma, Xing Li, Yanling Zhao, Yanling Zhao, Haotian Li, Jianxia Wen, Yuling Tong, Tao Yang and Honghong Liu and has published in prestigious journals such as Scientific Reports, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Manyi Jing

39 papers receiving 757 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis

2022 262 citations Xing Li, Shizhang Wei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manyi Jing China	15	365	225	128	110	102	43	768
Yanxi Zhou China	10	377 1.0×	116 0.5×	134 1.0×	199 1.8×	70 0.7×	16	964
Yongjian Xiong China	16	390 1.1×	149 0.7×	82 0.6×	67 0.6×	65 0.6×	31	819
Xiaobao Gong China	17	349 1.0×	137 0.6×	56 0.4×	58 0.5×	76 0.7×	25	742
Yeer Liang Macao	12	351 1.0×	126 0.6×	75 0.6×	59 0.5×	165 1.6×	13	710
Katsuya Ohbuchi Japan	15	372 1.0×	130 0.6×	139 1.1×	72 0.7×	35 0.3×	63	871
Lieqiang Xu China	16	373 1.0×	189 0.8×	63 0.5×	74 0.7×	95 0.9×	23	797
Ramesh B. Kasetti United States	23	632 1.7×	113 0.5×	74 0.6×	91 0.8×	135 1.3×	39	1.7k
Ting‐Lin Yen Taiwan	17	389 1.1×	129 0.6×	42 0.3×	188 1.7×	120 1.2×	49	939
Yiqi Yang China	15	424 1.2×	98 0.4×	72 0.6×	99 0.9×	204 2.0×	30	841
Chengmu Hu China	18	387 1.1×	117 0.5×	58 0.5×	75 0.7×	57 0.6×	33	848

Countries citing papers authored by Manyi Jing

Since Specialization

Citations

This map shows the geographic impact of Manyi Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manyi Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manyi Jing more than expected).

Fields of papers citing papers by Manyi Jing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manyi Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manyi Jing. The network helps show where Manyi Jing may publish in the future.

Co-authorship network of co-authors of Manyi Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Manyi Jing. A scholar is included among the top collaborators of Manyi Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manyi Jing. Manyi Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Shizhang, Lisheng Chen, Manyi Jing, et al.. (2024). The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury. Journal of Gastroenterology and Hepatology. 39(6). 1134–1144. 3 indexed citations

Wu, Wenbin, Yanling Sun, Xing Li, et al.. (2024). Integrated Microbiome and Metabolomic to Explore the Mechanism of Coptisine in Alleviating Ulcerative Colitis. Phytotherapy Research. 39(2). 676–697. 2 indexed citations

Chen, Lisheng, Honghong Liu, Xin Wang, et al.. (2024). Integrated Approaches Revealed the Therapeutic Mechanisms of Zuojin Pill Against Gastric Mucosa Injury in a Rat Model with Chronic Atrophic Gastritis. Drug Design Development and Therapy. Volume 18. 1651–1672. 10 indexed citations

Chang, Lei, Lisheng Chen, Yong He, et al.. (2023). Integrated network pharmacology and metabolomics to investigate the effects and possible mechanisms of Dehydroevodiamine against ethanol-induced gastric ulcers. Journal of Ethnopharmacology. 319(Pt 3). 117340–117340. 11 indexed citations

Wei, Shizhang, Xu Zhao, Manyi Jing, et al.. (2023). Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice. Frontiers in Pharmacology. 14. 1197847–1197847. 10 indexed citations

Chen, Lisheng, Shizhang Wei, Yong He, et al.. (2023). Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms. Pharmaceuticals. 16(9). 1308–1308. 13 indexed citations

Hu, Qichao, Jinhao Zeng, Xiaomei Zhang, et al.. (2023). Metabolomics Profiles Reveal the Efficacy of Wuzhuyu Decoction on Patients with Chronic Non-Atrophic Gastritis. Drug Design Development and Therapy. Volume 17. 3269–3280. 5 indexed citations

Wei, Shizhang, Xiao Ma, Ruilin Wang, et al.. (2023). Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. Frontiers in Pharmacology. 14. 1173542–1173542. 10 indexed citations

Ma, Xiao, Ruilin Wang, Zhong‐Xia Wang, et al.. (2022). Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis. Frontiers in Pharmacology. 13. 898680–898680. 10 indexed citations

10.

Jing, Manyi, Xiao Han, Minmin Luo, et al.. (2022). Activation of mesocorticolimbic dopamine projections initiates cue-induced reinstatement of reward seeking in mice. Acta Pharmacologica Sinica. 43(9). 2276–2288. 7 indexed citations

11.

Lv, Yang, Manyi Jing, Pei-Yun Li, et al.. (2022). Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens. Neuropharmacology. 208. 108986–108986. 7 indexed citations

12.

Li, Xing, Shizhang Wei, Xiao Ma, et al.. (2021). Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 35 indexed citations

13.

Chen, Lisheng, Shizhang Wei, Honghong Liu, et al.. (2021). Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 16 indexed citations

14.

Wang, Ruilin, Xia Liu, Manyi Jing, et al.. (2021). Zuojin Pill ameliorates inflammation in indomethacin-induced gastric injury via inhibition of MAPK pathway. Journal of Ethnopharmacology. 275. 114103–114103. 24 indexed citations

15.

Wang, Ruilin, et al.. (2021). Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 14 indexed citations

16.

Chen, Lisheng, Ruilin Wang, Honghong Liu, et al.. (2021). Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 10 indexed citations

17.

Niu, Ming, Ruisheng Li, Ruilin Wang, et al.. (2021). Mechanism of rutaecarpine on ethanol-induced acute gastric ulcer using integrated metabolomics and network pharmacology. Biomedicine & Pharmacotherapy. 138. 111490–111490. 35 indexed citations

18.

Ma, Xiao, Ruilin Wang, Honghong Liu, et al.. (2021). Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies. Frontiers in Pharmacology. 12. 742465–742465. 14 indexed citations

19.

Wen, Jianxia, Ruilin Wang, Honghong Liu, et al.. (2020). Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review. Chinese Medicine. 15(1). 48–48. 8 indexed citations

20.

Lv, Yang, Manyi Jing, Ning Wu, et al.. (2018). Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice. Acta Pharmacologica Sinica. 40(5). 583–588. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact